NCT05751226: A Study in People With Overweight or Obesity to Test How Well Different Doses of BI 1820237 Are Tolerated When Given Alone or in Combination With Either Semaglutide or BI 456906
- State
- Completed
- Phase
- Phase 1
- People
- 88 taking part
- Started
- 11 Apr 2023
- Primary completion
- 1 Aug 2024
- Arms
- BI 1820237 treatment group, BI 1820237 + semaglutide treatment group, BI 1820237 + BI 456906 treatment group
- Results
- None posted
- 2 Mar 2023: Trial registered
- 11 Apr 2023: Trial started
- 1 Aug 2024: Trial completed